Melatonin Administration as an Adjuvant Therapy in Preterm Infants with Neonatal Jaundice
Phase 3
Recruiting
- Conditions
- eonatal jaundice.Neonatal jaundice associated with preterm deliveryP59.0
- Registration Number
- IRCT20231210060317N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Gestational age 32-37 weeks
Serum bilirubin level below exchange transfusion threshold
Indirect hyperbilirubinemia
Postnatal age under 30 days
Exclusion Criteria
Underlying diseases and congenital anomalies in the neonate
Any signs of neonatal sepsis or other infections
Signs and risk factors of hemolysis
Acute or chronic respiratory diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum bilirubin level (mg/dL). Timepoint: Serum bilirubin levels will be measured in both groups before the intervention (T0), on the first day (T1), and on the second day (T2) after the intervention. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method